Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Nature Structural & Molecular Biology
|
February 4, 2012
Cbl exposes its RING finger
Stephen C Kales, Philip E Ryan, Stanley Lipkowitz
Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology
|
May 11, 2007
Calreticulin in rainbow trout: a limited response to endoplasmic reticulum (ER) stress
Stephen C Kales, Niels C Bols, Brian Dixon
Cancer Research
|
May 27, 2010
Cbl and human myeloid neoplasms: the Cbl oncogene comes of age
Stephen C Kales, Philip E Ryan, Marion M Nau, et al.
Plos One
|
January 28, 2014
Enigma prevents Cbl-c-mediated ubiquitination and degradation of RETMEN2A
Stephen C Kales, Marion M Nau, Anand S Merchant, et al.
Molecular Immunology
|
January 6, 2007
Response of the rainbow trout monocyte/macrophage cell line, RTS11 to the water molds Achlya and Saprolegnia
Stephen C Kales, Stephanie J DeWitte-Orr, Niels C Bols, et al.
Biology of the Cell
|
February 1, 2011
ARAP1 association with CIN85 affects epidermal growth factor receptor endocytic trafficking
Hye-Young Yoon, Stephen C Kales, Ruibai Luo, et al.
Immunogenetics
|
May 1, 2019
Immune stimulation of rainbow trout reveals divergent regulation of MH class II-associated invariant chain isoforms
Shawna L Semple, George Heath, Darah Christie, et al.
Plos One
|
November 13, 2012
Cbl-c ubiquitin ligase activity is increased via the interaction of its RING finger domain with a LIM domain of the paxillin homolog, Hic 5
Philip E Ryan, Stephen C Kales, Rajgopal Yadavalli, et al.
Biorxiv : the Preprint Server for Biology
|
June 30, 2020
An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19
Jonathan H Shrimp, Stephen C Kales, Philip E Sanderson, et al.
ACS Pharmacology & Translational Science
|
October 16, 2020
An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19
Jonathan H Shrimp, Stephen C Kales, Philip E Sanderson, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Nature Structural & Molecular Biology
|
February 4, 2012
Cbl exposes its RING finger
Stephen C Kales, Philip E Ryan, Stanley Lipkowitz
Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology
|
May 11, 2007
Calreticulin in rainbow trout: a limited response to endoplasmic reticulum (ER) stress
Stephen C Kales, Niels C Bols, Brian Dixon
Cancer Research
|
May 27, 2010
Cbl and human myeloid neoplasms: the Cbl oncogene comes of age
Stephen C Kales, Philip E Ryan, Marion M Nau, et al.
Plos One
|
January 28, 2014
Enigma prevents Cbl-c-mediated ubiquitination and degradation of RETMEN2A
Stephen C Kales, Marion M Nau, Anand S Merchant, et al.
Molecular Immunology
|
January 6, 2007
Response of the rainbow trout monocyte/macrophage cell line, RTS11 to the water molds Achlya and Saprolegnia
Stephen C Kales, Stephanie J DeWitte-Orr, Niels C Bols, et al.
Biology of the Cell
|
February 1, 2011
ARAP1 association with CIN85 affects epidermal growth factor receptor endocytic trafficking
Hye-Young Yoon, Stephen C Kales, Ruibai Luo, et al.
Immunogenetics
|
May 1, 2019
Immune stimulation of rainbow trout reveals divergent regulation of MH class II-associated invariant chain isoforms
Shawna L Semple, George Heath, Darah Christie, et al.
Plos One
|
November 13, 2012
Cbl-c ubiquitin ligase activity is increased via the interaction of its RING finger domain with a LIM domain of the paxillin homolog, Hic 5
Philip E Ryan, Stephen C Kales, Rajgopal Yadavalli, et al.
Biorxiv : the Preprint Server for Biology
|
June 30, 2020
An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19
Jonathan H Shrimp, Stephen C Kales, Philip E Sanderson, et al.
ACS Pharmacology & Translational Science
|
October 16, 2020
An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19
Jonathan H Shrimp, Stephen C Kales, Philip E Sanderson, et al.
Page
of 4